Identification of HMGB2 associated with proliferation, invasion and prognosis in lung adenocarcinoma via weighted gene co-expression network analysis

[1]  Long Zhao,et al.  LINC00184 plays an oncogenic role in non‐small cell lung cancer via regulation of the miR‐524‐5p/HMGB2 axis , 2021, Journal of cellular and molecular medicine.

[2]  N. Lou,et al.  High-mobility group box 2 reflects exacerbated disease characteristics and poor prognosis in non-small cell lung cancer patients , 2021, Irish Journal of Medical Science (1971 -).

[3]  K. Gao,et al.  Imperatorin inhibits the invasion and migration of breast cancer cells by regulating HMGB2. , 2021, Journal of biological regulators and homeostatic agents.

[4]  Nadezhda T. Doncheva,et al.  The STRING database in 2021: customizable protein–protein networks, and functional characterization of user-uploaded gene/measurement sets , 2020, Nucleic Acids Res..

[5]  I. Jonassen,et al.  Proteogenomics of Non-smoking Lung Cancer in East Asia Delineates Molecular Signatures of Pathogenesis and Progression , 2020, Cell.

[6]  W. Lei,et al.  TSN inhibits cell proliferation, migration, invasion and EMT through regulating miR-874/HMGB2/β-catenin pathway in gastric cancer. , 2020, Neoplasma.

[7]  Jingjing Xie,et al.  Bioinformatics analysis of the prognosis and biological significance of HMGB1, HMGB2, and HMGB3 in gastric cancer , 2019, Journal of cellular physiology.

[8]  Sharyn I. Katz,et al.  Lung Cancer Surveillance After Definitive Curative-Intent Therapy: ASCO Guideline. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[9]  Beibei Ru,et al.  TISIDB: an integrated repository portal for tumor-immune system interactions , 2019, Bioinform..

[10]  J. Molina,et al.  Non-Small Cell Lung Cancer: Epidemiology, Screening, Diagnosis, and Treatment. , 2019, Mayo Clinic proceedings.

[11]  Zemin Zhang,et al.  GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis , 2019, Nucleic Acids Res..

[12]  Ling Gao,et al.  HMGB2 promotes the malignancy of human gastric cancer and indicates poor survival outcome. , 2019, Human pathology.

[13]  Yiyu Lu,et al.  Overexpression of miR-758 inhibited proliferation, migration, invasion, and promoted apoptosis of non-small cell lung cancer cells by negatively regulating HMGB , 2018, Bioscience reports.

[14]  Wei Liu,et al.  CancerSEA: a cancer single-cell state atlas , 2018, Nucleic Acids Res..

[15]  P. Carmeliet,et al.  Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.

[16]  I. Wistuba,et al.  A novel protein‐based prognostic signature improves risk stratification to guide clinical management in early‐stage lung adenocarcinoma patients , 2018, The Journal of pathology.

[17]  S. Chi,et al.  Transcriptional Repression of High-Mobility Group Box 2 by p21 in Radiation-Induced Senescence , 2018, Molecules and cells.

[18]  Chuanli Ren,et al.  HMGB2 is associated with malignancy and regulates Warburg effect by targeting LDHB and FBP1 in breast cancer , 2018, Cell Communication and Signaling.

[19]  A. Naiki‐Ito,et al.  Early detection of prostate carcinogens by immunohistochemistry of HMGB2. , 2018, The Journal of toxicological sciences.

[20]  Q. Fan,et al.  Long Noncoding RNA NEAT1 Promotes Proliferation and Invasion via Targeting miR-181a-5p in Non-Small Cell Lung Cancer. , 2018, Oncology research.

[21]  Jing-hua Zhang,et al.  Long non-coding RNA MALAT1 drives gastric cancer progression by regulating HMGB2 modulating the miR-1297 , 2017, Cancer Cell International.

[22]  Zhen Yang,et al.  Expression of HMGB2 indicates worse survival of patients and is required for the maintenance of Warburg effect in pancreatic cancer , 2017, Acta biochimica et biophysica Sinica.

[23]  C. Zappa,et al.  Non-small cell lung cancer: current treatment and future advances. , 2016, Translational lung cancer research.

[24]  J. Mesirov,et al.  The Molecular Signatures Database Hallmark Gene Set Collection , 2015 .

[25]  Y. Shang,et al.  miR-23b-3p regulates the chemoresistance of gastric cancer cells by targeting ATG12 and HMGB2 , 2015, Cell Death and Disease.

[26]  J. Mesirov,et al.  The Molecular Signatures Database (MSigDB) hallmark gene set collection. , 2015, Cell systems.

[27]  J. Carroll,et al.  Genomic interaction between ER and HMGB2 identifies DDX18 as a novel driver of endocrine resistance in breast cancer cells , 2014, Oncogene.

[28]  Juan Chen,et al.  Association of HMGB1 and HMGB2 genetic polymorphisms with lung cancer chemotherapy response , 2014, Clinical and experimental pharmacology & physiology.

[29]  Jun Wang,et al.  Challenges to effective cancer control in China, India, and Russia. , 2014, The Lancet. Oncology.

[30]  Fumihiro Tanaka,et al.  Recurrence after surgery in patients with NSCLC. , 2014, Translational lung cancer research.

[31]  S. Lam,et al.  Genome-scale analysis of DNA methylation in lung adenocarcinoma and integration with mRNA expression , 2012, Genome research.

[32]  R. Salgia,et al.  The database of chromosome imbalance regions and genes resided in lung cancer from Asian and Caucasian identified by array-comparative genomic hybridization , 2012, BMC Cancer.

[33]  N. Krynetskaia,et al.  Chromatin-associated proteins HMGB1/2 and PDIA3 trigger cellular response to chemotherapy-induced DNA damage , 2009, Molecular Cancer Therapeutics.

[34]  Kenta Nakai,et al.  PrognoScan: a new database for meta-analysis of the prognostic value of genes , 2009, BMC Medical Genomics.

[35]  S. Wacholder,et al.  Gene Expression Signature of Cigarette Smoking and Its Role in Lung Adenocarcinoma Development and Survival , 2008, PloS one.

[36]  James L Mulshine,et al.  Lung cancer screening. , 2005, The oncologist.

[37]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[38]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..

[39]  Judy Lieberman,et al.  HMG2 Interacts with the Nucleosome Assembly Protein SET and Is a Target of the Cytotoxic T-Lymphocyte Protease Granzyme A , 2002, Molecular and Cellular Biology.

[40]  J. O. Thomas,et al.  HMG1 and 2: architectural DNA-binding proteins. , 2001, Biochemical Society transactions.

[41]  P. Sharp,et al.  Activation of the TFIID-TFIIA complex with HMG-2. , 1995, Genes & development.